Page 7 - MEOG Week 42 2022
P. 7

MEOG                                  FINANCE & INVESTMENT                                            MEOG


       Capricorn shareholder




       rails against NewMed deal




        ISRAEL           NEW York-based hedge fund Irenic Capital  the East Med Gas (EMG) pipeline stakes, as well
                         Management this week called on Capricorn  as 30% in Cyprus’ 3.5 trillion cubic foot (10bn
                         Energy to bail on a deal to sell and merge with  cubic metre) Aphrodite gas field and the onshore
                         NewMed Energy, urging it to sell its assets  Israeli New Ofek and New Yahel licences. It will
                         individually.                        also receive royalties from the Karish and Tanin
                           Irenic holds a 1.5% share in Capricorn and  fields, which were sold to fellow London-listed
                         issued a letter – seen by Reuters – to the firm’s  Energean in 2016.
                         board suggesting that auctioning the assets could   The Leviathan partners agreed in January to
                         achieve a 43$ premium compared to the current  spend around $235mn to construct the EMG
                         share price and almost 40% up on the NewMed  pipeline allowing for direct gas exports from the
                         deal. “The company has yet to present sharehold-  assets to Egypt.
                         ers with any proposal that represents superior   Leviathan holds about 18.9 tcf (535 bcm)
                         value relative to the straightforward liquidation  and NewMed CEO Yossi Abu, who retains his
                         value we have assessed,” Irenic said.  position as the head of the merged entity, said
                           IF it were to withdraw from the deal, it would  earlier in the year that the field could yield 21
                         be the second merger Capricorn has pulled out  bcm per year following the development of its
                         of this year, having backed away from a merger  second phase.
                         with Tullow Oil to take the NewMed deal.  Capricorn’s production focuses on Egypt and
                           While Irenic said the NewMed merger was  Abu said that NewMed would look to raise out-
                         more attractive than the Tullow option, it said  put from the current 115,000 barrels of oil equiv-
                         the deal had “limited strategic rationale” aside  alent per day to beyond 200,000 boepd by 2030.
                         from offering NewMed a premium listing on the   He added that options including floating
                         London Stock Exchange.               LNG (FLNG) and a pipeline to Egypt are being
                           If it goes ahead, the agreement will see share-  considered for the development of the field.
                         holders in Capricorn – formerly Cairn Energy   In September 2021, Delek finalised the sale
                         – receive a special dividend of $620mn and the  of its 22% stake in the Tamar gas field to Abu
                         new entity will be listed under NewMed – for-  Dhabi’s Mubadala Petroleum for around $1bn.
                         merly Delek Drilling – whose shareholders will  This saw it meet a mid-December deadline
                         hold an 89.7% stake in the new “MENA gas and  for divesting the stake in order to comply with
                         energy champion”.                    a controversial anti-trust settlement reached
                           NewMed’s assets comprise equal 45.33%  in 2015, allowing it to retain the Leviathan
                         stakes in Israel’s giant Leviathan gas field and  shareholding.™         Source: NewMed Energy






































       Week 42   19•October•2022                www. NEWSBASE .com                                              P7
   2   3   4   5   6   7   8   9   10   11   12